Recent development in the field of dual COX / 5-LOX inhibitors

Fabien Julémont, Jean-Michel Dogné, Bernard Pirotte, Xavier de Leval

Résultats de recherche: Contribution à un journal/une revueArticleRevue par des pairs

Résumé

Cyclooxygenases and lipoxygenase are key enzymes in the arachidonic acid metabolism. Dual inhibitors are drugs able to block both the COX and the 5-LOX metabolic pathways. Compared to COX or LOX pathways single inhibitors, dual inhibitors present at least two major advantages. First, dual inhibitors, by acting on the two major arachidonic acid metabolic pathways, possess a wide range of anti-inflammatory activities. Secondly, dual inhibitors appear to be almost exempt from gastric toxicity, which is the most troublesome side effect of non-selective COX inhibitors.
langue originaleAnglais
Pages (de - à)633-8
Nombre de pages6
journalMini-reviews in medicinal chemistry
Volume4
Numéro de publication6
Etat de la publicationPublié - août 2004

Empreinte digitale

Examiner les sujets de recherche de « Recent development in the field of dual COX / 5-LOX inhibitors ». Ensemble, ils forment une empreinte digitale unique.

Contient cette citation